The role of endothelin in the pathophysiology of glaucoma

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 6, 2010, Pages 647-654

  Good, Travis J ^a   Kahook, Malik Y ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelin; ET 1; Glaucoma; Intraocular pressure

Indexed keywords

ANTIGLAUCOMA AGENT; AVOSENTAN; BOSENTAN; BUNAZOSIN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; FLUPROSTENOL; POLYPHENOL; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SULFAFURAZOLE; UNOPROSTONE ISOPROPYL ESTER;

BLINDNESS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG TARGETING; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR BLOCKING; RETINA GANGLION CELL; REVIEW; VASOCONSTRICTION; VASODILATATION;

ANIMALS; DISEASE PROGRESSION; DRUG DELIVERY SYSTEMS; ENDOTHELINS; EYE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; VASOCONSTRICTION;

EID: 77952306417     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2010.487065     Document Type: Review

References (77)

1. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of glaucoma among adults in the United States. Arch Ophthalmol 2004;122:532-8
2. Ramulu P, Friedman DS. Epidemiology of glaucoma. In: Yanoff M, Duker JS, editors, Ophthalmology. 3rd edition. Chapter 10.1. Mosby, Inc., Maryland Heights, MO; 2008
3. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992;99:1499-504
4. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004;111:1641-8
5. Shiose Y, Kitazawa Y, Tsukahara S, et al. Epidemiology of glaucoma in Japan-a nationwide glaucoma survey. Jpn J Ophthalmol 1991;35:133-55
6. Shields MB. Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 2008;19:85-8
7. Moore D, Harris A, Wudunn D, et al. Dysfuctional regulation of ocular blood flow: a risk factor for glaucoma? Clin Ophtalmol 2008;2:849-61
8. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002;21:359-93
9. Levin ER. Endothelins. N Engl J Med 1995;333:356-63
10. Davenport AP. International union of pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 2002;54:219-26
11. Haynes WG, Hand MF, Johnstone HA, et al. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1. J Clin Invest 1994;94:1359-64
12. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5
13. Shah R. Endothelin in health and disease. Eur J Int Med 2007;18:272-82
14. Nakano A, Kishi F, Ninami K. Selective conversion of big endothelins to tracheal smooth muscle constricting 31 amino-acid-length endothelins by chymase from human mast cells. J Immunol 1997;159:1987-92
15. Xu D, Emoto N, Giaid A, et al. ECE-1: a membrance-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994;78:473-84
16. Arai H, Hori S, Aramori I, et al. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2
17. Takuwa Y, Kasuya Y, Takuwa N, et al. Endothelin receptor is coupled to phospholipase C via a pertussis toxin-intensive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells. J Clin Invest 1990;85:653-8
18. Suzuki S, Kajikuri J, Suzuki A, Itoh T. Effects of endothelin in the porcine coronary artery. Circ Res 1991;69:1361-8
19. Schneider MP, Boesen EI, Pollock DM. Contrasting actions of endothelin ETA and ETB receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol 2007;47:731-59
20. Bremmes T, Paasche JD, Mehlum A, et al. Regulation of intracellular trafficking pathways of the endothelin receptors. J Biol Chem 2000;275:17596-604
21. Yorio T, Krishnamoorthy R, Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology. J Glaucoma 2002;11:259-70
22. MacCumber MW, D'Anna SA. Endothelin receptor-binding subtypes in the human retina and choroid. Arch Opthalmol 1994;112:1231-5
23. MacCumber MW, Ross CA, Glaser BM, Snyder SH. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 1989;86:7285-9
24. Bausher LP. Endothelins inhibit cyclic AMP production in rabbit and human cilliary processes. J Ocul Pharmacol Ther 1995;11:135-43
25. Ripodas A, de Juan JA, Roldan-Pallares M, et al. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res 2001;912:137-43
26. Rao VR, Krishnamoorthy RR, Yorio T. Endothelin-1, endothelin A and B receptor expression and their pharmacological properties in GFAP negative human lamina cribrosa cells. Exp Eye Res 2007;84:1115-24
27. Lepple-Wienhues A, Becker M, Stahl F, et al. Endothelin-like immunoreactivity in the aqueous humour and in conditioned medium from cultured ciliary epithelial cells. Curr Eye Res 1992;11:1041-6
28. Sigiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 1997; 39: S49-56
29. Koliakos GG, Konstas AGP, Schlotzer-Schrehardt U, et al. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2004;88:523-7
30. Noske W, Hensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humour of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol 1997;235:551-2
31. Emre M, Orgul S, Haufschild T, et al. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol 2005;89:60-3
32. Kunimatsu S, Mayama C, Tomidokoro A, Araie M. Normal endothelin-a level in Japanese normal tension glaucoma patients. Curr Eye Res 2006;31:727-31
33. Nicolela MT, Ferrier SN, Morrison CA, et al. Effects of cold-induced vasospasm in glaucoma: the role of endothelin-1. Invest Ophthalmol Vis Sci 2003;44:2565-72
34. Wang L, Fortune B, Cull G, et al. Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage. Arch Ophthalmol 2006;124:717-24
35. Prasanna G, Hulet C, Desai D, et al. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol Res 2005;51:41-50
36. Polak K, Petternel V, Luksch K, et al. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects. Invest Ophthalmol Vis Sci 2001;42:2949-56
37. Polak K, Luksch A, Frank B, et al. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res 2003;76:633-40
38. Schmetterer L, Findl O, Strenn K, et al. Effects of endothelin-1 (ET-1) on ocular hemodynamics. Curr Eye Res 2007;16:687-92
39. Hein TW, Ren Y, Yuan Z, et al. Functional and molecular characterization of the endothelin system in retinal arterioles. Invest Ophthalmol Vis Sci 2009;50:3329-36
40. Rigosi E, Ensini M, Bottari D, et al. Loss of retinal capillary vasoconstrictor response to endothelin-1 following pressure increments in living isolated rat retinas. Exp Eye Res 2010;90:33-40
41. Stumpff F, Wiederholt M. Regulation of trabecular meshwork contractility. Ophthalmologica 2002;214:33-53
42. Choritz L, Rosenthal R, Fromm M, et al. Pharmacological and functional characterization of endothelin receptors in bovine trabecular meshwork and ciliary muscle. Ophthalmic Res 2005;37:179-87
43. Cellini M, Versura P, Trere D, Campos EC. Effects of endothelin-1 on human trabecular meshwork cell contraction. Ophthalmic Res 2005;37:43-9
44. Lau J, Dang M, Hockman K, Ball AK. Effect of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat. Exp Eye Res 2006;82:132-45
45. Munemasa Y, Kitaoka Y, Hayashi Y, et al. Effect on unoprostone on phosphorylated extracellular signal-regulated kinase in endothelin-1 induced retinal and optic nerve damage. Vis Neurosci 2008;25:197-208
46. Wang X, LeVatte TL, Archibald M, Chauhan BC. Increase in endothelin B receptor expression in optic nerve astrocytes in endothelin-1 induced chronic optic neuropathy. Exp Eye Res 2009;88:378-85
47. Chauhan BC, LeVatte TL, Jollimore CA, et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci 2004;45:144-52
48. Krishnamoorthy RR, Vidhya RR, Dauphin R, et al. Role of ETB receptor in retinal cell death in glaucoma. Can J Physiol Pharmacol 2008;86:380-93
49. Prasanna G, Krishnamoorthy R, Clark AF, et al. Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci 2002;43:2704-13
50. Hollander H, Makarov F, Sepfani FH, Stone J. Evidence of contraction of optic nerve axons at the lamina cribrosa in the normotensive eye in humans and other animals. Ophthalmic Res 1995;27:296-309
51. Stokely ME, Brady ST, Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Invest Ophthalmol Vis Sci 2002;43:3223-30
52. Rao VR, Krishnamoorthy RR, Yorio T. Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa. Exp Eye Res 2008;86:886-94
53. Okuno T, Oku H, Sugiyama T, et al. Evaluation of nitric oxide synthesis in the optic nerve head in vivo using microdialysis and high performance liquid chematography and its interaction with endothelin-1. Ophthalmic Res 2003;35:78-83
54. Izzotti A, Sacca SC, Longobardi M, Cartiglia C. Sensitivity of ocular anterior chamber tissues to oxidative damage and its relevance to the pathogenesis of glaucoma. Invest Ophthalmol Vis Sci 2009;50:5251-58
55. Sacca SC, Pascotto A, Camicione P, et al. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 2005;123:458-63
56. Izzotti A, Cartiglia C, De Flora S, Sacca S. Methodology for evaluating oxidative DNA damage and metabolic genotypes in human trabecular meshwork. Tox Mech Method 2003;13:161-8
57. Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 2003;114:638-46
58. Zhang X, Clark AF, Yorio T. Interaction of endothelin-1 with dexamethasone in primary cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2003;44:5301-8
59. Zhang X, Krishnamoorthy R, Prasanna G, et al. Dexamethasone regulates endothelin-1 and endothelin receptors in human non-pigmented ciliary epithelial (HNPE) cells. Exp Eye Res 2003;76:261-72
60. Podos SM, Wang RF, Serle JB, Baltatu OC. Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes. Invest Ophthalmol Vis Sci 2009; 50: E-Abstract 1476
61. Yorio T, Krishnamoorthy R, Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma 2002;11:259-70
62. Resch H, Karl K, Weigert G, et al. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci 2009;50:358-63
63. Syed H, Safa R, Chidlow G, Osborne NN. Sulfisoxazole, an endothelin receptor antagonist, protects retinal neurones from insults of ischemia/reperfusion of lipopolysaccharide. Neurochem Int 2006;48:708-17
64. Goto W, Oku H, Okuno T, et al. Amelioration of endothelin-1-induced optic nerve head ischemia by topical bunazosin. Curr Eye Res 2005;30:81-91
65. Forster BA, Ferrari-Dileo G, Anderson DR. Adrenergic alpha1 and alpha2 binding sites are present in bovine retinal blood vessels. Invest Ophthalmol Vis Sci 1987;28:1741-6
66. Ichikawa M, Okada Y, Asai Y, et al. Effects of topically instilled bunazosin, an alpha1-adrenoceptor antagonist, on constrictions induced by phenylephrine and ET-1 in rabbit retinal arteries. Invest Ophthalmol Vis Sci 2004;45:4041-8
67. Kotake H, Noguchi N, Matsuoka S, et al. Bunazosin, an alpha-adrenoceptor antagonist, blocks calcium current in guinea-pig ventricular myocytes. Comp Biochem Physiol C 1991;100:401-4
68. Thieme H, Schimmat C, Munzer G, et al. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci 2006;47:938-45
69. Villumsen J, Alm A, Soderstrom M. Prostaglandin F2alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma. Br J Ophthalmol 1989;73:975-9
70. Alm A. Prostaglandin derivates as ocular hypotensive agents. Prog Retin Eye Res 1998;17:291-312
71. Lindsey JD, Kashiwagi K, Boyle D, et al. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res 1996;15:869-75
72. Lindsey JD, Kashiwagi K, Kashiwagi F, et al. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci 1997;38:2214-23
73. Nordmann JP, Rouland JF, Mertz BP. A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension. Curr Med Res Opin 1999;15:87-93
74. Kimura I, Shinoda K, Tanino T, et al. Effect of topical unoprostone isopropyl on optic nerve head circulation in controls and in normal-tension glaucoma patients. Jpn J Ophthalmol 2005;49:287-93
75. Thieme H, Stumpff F, Ottlecz A, et al. Mechanism of action of unoprostone on trabecular meshwork contractility. Invest Ophthamol Vis Sci 2001;42:3193-201
76. Corder RR, Douthwaite JA, Lees DM, et al. Endothelin-1 synthesis reduced by red wine. Nature 2001;414:863-4
77. Haufschild T, Kaiser HJ, Preiseg T, et al. Influence of red wine on visual function and endothelin-1 plasma level in a patient with optic neuritis. Ann Neurol 2003;53:825-6